Weight Regain After Stopping Weight Loss Drugs: What the Latest Research Shows

Patients who discontinue GLP-1 receptor agonist medications, such as Ozempic and Wegovy, typically regain weight, but a significant portion of weight loss may be sustained long-term, according to recent research. A study published in eClinicalMedicine found that approximately 60% of weight lost during therapy is regained within one year, but individuals may retain around a quarter of the weight loss in the long run.

Understanding GLP-1 Receptor Agonists

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become popular for weight management due to their ability to suppress appetite and promote feelings of fullness. Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide are examples of GLP-1RAs. Ozempic is approved for treating type 2 diabetes, while Wegovy is approved for obesity.

The Trajectory of Weight Regain

The University of Cambridge study, led by Brajan Budini, analyzed data from 48 studies involving 3,236 participants. The research indicates that weight regain is rapid initially, then slows down over time. Researchers modeled weight regain using a nonlinear exponential approach. The study suggests a potential plateau around 75% of the original weight lost, meaning about 25% of weight loss could be maintained long-term. University of Cambridge.

Factors Influencing Weight Regain

Several factors contribute to discontinuation of GLP-1RA therapy, including:

• Gastrointestinal side effects
• Financial costs (treatment can cost several hundred euros per month, and is generally not covered by statutory health insurance in Germany)
• Limited access through health insurance or prescription policies

The average initial weight of participants in the studies ranged from 104 to 112 kilograms. Those taking semaglutide lost, on average, 11 to 17 percent of their body weight over a period of more than three years. Participants using tirzepatide experienced weight loss of 15 to 23 percent over a similar timeframe. Ground News.

The Importance of Long-Term Management

The study highlights the need for long-term weight management strategies. Approximately half of individuals who initiate GLP-1RA therapy discontinue it prematurely, suggesting that continued treatment may be necessary to sustain weight loss. Researchers are exploring strategies like reducing the dosage after reaching target weight to improve long-term tolerability and maintenance. medRxiv.

Weight Loss and Lifestyle Factors

Research from the Beijing University People’s Hospital indicates that the amount of weight lost influences the amount regained. Individuals who lose more weight tend to regain more, even when participating in lifestyle modification programs. This phenomenon is similar to what is observed in individuals following severely calorie-restricted diets. Medical Xpress.

Key Takeaways

• Weight regain is common after stopping GLP-1RA medications.
• Approximately 60% of lost weight is regained within one year.
• Around 25% of weight loss may be sustained long-term.
• Long-term weight management strategies are crucial for maintaining results.
• Discontinuation is often due to side effects, cost, or access issues.